Tekmira to suspend Ebola drug development, focus on hepatitis B

Tekmira to suspend Ebola drug development, focus on hepatitis B

Add Comment Edit

Tekmira Ebola Drug 20150619

Tekmira Pharmaceuticals Corp., based in Burnaby, B.C., announced on Monday that their TKM-Ebola drug will no longer be produced.



from CBC | Health News http://ift.tt/1fhEAdx

Share this:

ABOUT THE AUTHOR

Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible

0 commentaires:

Enregistrer un commentaire

Inscription à : Publier les commentaires ( Atom )